Dec. 11 2025
Source Page: Supporting spreadsheets for allocations 2026/27 to 2028/29Dec. 11 2025
Source Page: Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemiaDec. 11 2025
Source Page: Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemiaDec. 11 2025
Source Page: Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemiaDec. 11 2025
Source Page: Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemiaDec. 11 2025
Source Page: Principles for providing patient care in corridorsDec. 11 2025
Source Page: Vutrisiran for treating transthyretin amyloidosis with cardiomyopathyDec. 10 2025
Source Page: Vutrisiran for treating transthyretin amyloidosis with cardiomyopathyDec. 10 2025
Source Page: Vutrisiran for treating transthyretin amyloidosis with cardiomyopathyDec. 10 2025
Source Page: Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy